Scorpius Holdings Terminates Material Agreement
Ticker: SCPX · Form: 8-K · Filed: Aug 9, 2024 · CIK: 1476963
| Field | Detail |
|---|---|
| Company | Scorpius Holdings, Inc. (SCPX) |
| Form Type | 8-K |
| Filed Date | Aug 9, 2024 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $0.0002, $0.002, $0.93, $0.929814, $1.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: agreement-termination, company-update
Related Tickers: SCPX
TL;DR
SCPX terminated a big deal, watch for fallout.
AI Summary
Scorpius Holdings, Inc. announced on August 6, 2024, the termination of a material definitive agreement. The company, formerly known as NightHawk Biosciences, Inc. and HEAT BIOLOGICS, INC., is based in Morrisville, NC.
Why It Matters
The termination of a material definitive agreement can significantly impact a company's operations, financial standing, and future strategic direction.
Risk Assessment
Risk Level: medium — Termination of a material definitive agreement introduces uncertainty regarding the company's business strategy and financial projections.
Key Players & Entities
- Scorpius Holdings, Inc. (company) — Registrant
- NightHawk Biosciences, Inc. (company) — Former company name
- HEAT BIOLOGICS, INC. (company) — Former company name
- August 6, 2024 (date) — Date of earliest event reported
FAQ
What was the nature of the material definitive agreement that was terminated?
The filing does not specify the nature of the material definitive agreement that was terminated, only that it occurred on or before August 6, 2024.
When was the termination of the material definitive agreement effective?
The filing indicates that August 6, 2024, is the date of the earliest event reported, which includes the termination of a material definitive agreement.
What is the primary business of Scorpius Holdings, Inc.?
Scorpius Holdings, Inc. is in the Pharmaceutical Preparations industry (SIC code 2834).
Has Scorpius Holdings, Inc. undergone any name changes?
Yes, Scorpius Holdings, Inc. was formerly known as NightHawk Biosciences, Inc. (name change effective May 2, 2022) and prior to that, HEAT BIOLOGICS, INC. (name change effective November 17, 2009).
Where is Scorpius Holdings, Inc. located?
Scorpius Holdings, Inc. is located in Morrisville, North Carolina.
Filing Stats: 1,396 words · 6 min read · ~5 pages · Grade level 12.9 · Accepted 2024-08-09 17:05:44
Key Financial Figures
- $0.0002 — nge on which registered Common Stock, $0.0002 par value per share SCPX NYSE America
- $0.002 — f the Company's common stock, par value $0.002 per share (the "Common Stock"), or pre-
- $0.93 — in lieu thereof, at a purchase price of $0.93 per Share and $0.929814 per Pre-Funded
- $0.929814 — a purchase price of $0.93 per Share and $0.929814 per Pre-Funded Warrant (93% of the publ
- $1.00 — he over-allotment option, at a price of $1.00 per share (inclusive of the Pre-Funded
Filing Documents
- scpx_8k.htm (8-K) — 42KB
- ex99x1.htm (EX-99.1) — 7KB
- ex99x2.htm (EX-99.2) — 13KB
- image_002.jpg (GRAPHIC) — 10KB
- 0001079973-24-001194.txt ( ) — 299KB
- scpx-20240806.xsd (EX-101.SCH) — 3KB
- scpx-20240806_def.xml (EX-101.DEF) — 26KB
- scpx-20240806_lab.xml (EX-101.LAB) — 36KB
- scpx-20240806_pre.xml (EX-101.PRE) — 25KB
- scpx_8k_htm.xml (XML) — 5KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Exhibit Description 1.1 Form of Underwriting Agreement (incorporated by reference to Exhibit 1.2 to the Registration Statement on Form S-1/A filed with the Securities and Exchange Commission on August 1, 2024 (333-280887)) 99.1 Press Release, dated August 9, 2024 99.2 Stockholder Letter, dated August 9, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 9, 2024 SCORPIUS HOLDINGS, INC. By: /s/ Jeffrey Wolf Name: Jeffrey Wolf Title: Chairman, President and Chief Executive Officer